Bibliography
Export 1797 results:
Filters: Keyword is Humans [Clear All Filters]
Malignancy after transplantation. Transplantation. 2005;80(2 Suppl):S254-64.
Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc. 2005;37(2):1243-4.
Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts. Transfusion. 2005;45(6):874-8.
Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant. 2005;5(11):2740-4.
A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion. 2005;45(2):254-64.
Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility. Clin Lab Haematol. 2005;27(3):206-8.
Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. Journal of Hepatology. 2005;42(6):813-9.
Paradoxical embolism after peripheral blood stem cell infusion. Bone Marrow Transplant. 2005;36(6):561-2.
Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation. American journal of hematology//Am J Hematol. 2005;79(4):299-302.
Pilot study of early corticosteroid elimination after pancreas transplantation. Transplant Proc. 2005;37(2):1287-8.
Pneumonia caused by Trichosporon pullulans in an autologous peripheral blood stem cell transplant recipient: possible misidentification. Bone Marrow Transplant. 2005;35(12):1219-20.
Post-transplant lymphoproliferative disorder. Clin Chest Med. 2005;26(4):631-45, - vii.
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc. 2005;37(2):954-5.
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. CritRevOncolHematol. 2005;56(1):155-167.
Preventing disease transmission by deceased tissue donors by testing blood for viral nucleic acid. Cell Tissue Bank. 2005;6(4):255-62.
Prion diseases and iatrogenic infections I. A review. Ig Sanita Pubbl. 2005;61(4):325-77.
Prions: who should worry about them? Arch Med Res. 2005;36(6):622-7.
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):958-9.
Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. ArchNeurol. 2005;62(6):73.
Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma. 2005;46(11):1671-4.
Renal artery aneurysm secondary to Candida albicans in four kidney allograft recipients. Transplant Proc. 2005;37(6):2834-6.
A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation. 2005;79(6 Suppl):S53-66.
Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study. Transplantation proceedings//Transplant Proc. 2005;37(2):1238-9.